
°í·Á´ëÇб³ ¾È¾Ïº´¿ø ³»ºÐºñ³»°ú ±èÁ¤¾Æ ±³¼ö(»çÁø)°¡ Áö³´Þ 25¡27ÀÏ ¼¿ï ±×·£µå ¿öÄ¿Èú¿¡¼ °³ÃÖµÈ ´ëÇÑ´ç´¢º´ÇÐȸ ±¹Á¦Çмú´ëȸ ¡®2025 KDA Scientific Meeting: 15th International Congress of Diabetes and Metabolism (ICDM2025)¡¯¿¡¼ ÃÖ¿ì¼ö±¸¿¬»óÀ» ¼ö»óÇß´Ù.
±èÁ¤¾Æ ±³¼ö´Â ±¸¿¬ ¹ßÇ¥ÇÑ ¿¬±¸ ¡®Liver-related complications and mortality in type 1 and type 2 diabetes with metabolic dysfunction associated steatotic liver disease¡¯ÀÇ ¿ì¼ö¼ºÀ» ÀÎÁ¤¹Þ¾Æ À̹ø ¼ö»óÀÇ ÁÖÀΰøÀÌ µÆ´Ù.
±èÁ¤¾Æ ±³¼ö´Â À̹ø ¿¬±¸ ¹ßÇ¥¿¡¼ ´ë»çÀÌ»óÁö¹æ°£Áúȯ(MASLD)ÀÌ ÀÖ´Â 1Çü ¹× 2Çü ´ç´¢º´È¯ÀÚ¿¡¼ °£°ü·Ã ÇÕº´ÁõÀÌ Áõ°¡Çß°í, ƯÈ÷ 1Çü ´ç´¢º´È¯ÀÚ¿¡¼ ±× À§Çèµµ°¡ Áõ°¡ÇÔÀ» ¹àÇô ÇаèÀÇ ÁÖ¸ñÀ» ¹Þ¾Ò´Ù.
±èÁ¤¾Æ ±³¼ö´Â À̹ø ¿¬±¸ °á°ú¿¡ ´ëÇØ, ¡°À̹ø ¿¬±¸´Â Á¦1Çü ´ç´¢º´ ȯÀÚ¿¡¼ ´ë»çÀÌ»óÁö¹æ°£ÁúȯÀÇ ÀÓ»óÀû À§Ç輺À» ±Ô¸íÇÑ ¿¬±¸¶ó´Â Á¡¿¡¼ Àǹ̰¡ Å©´Ù¡±¸ç, ¡°ÇâÈÄ ´ç´¢º´ ȯÀÚ¿¡¼ MASLD¿¡ ´ëÇÑ Àû±ØÀûÀÎ ¼±º°°Ë»ç¿Í ÇÔ²² Ç÷´ç¡¤´ë»ç ÁöÇ¥ ¹× ºñ¸¸¿¡ ´ëÇÑ Á¶±â °ü¸®°¡ ÇÊ¿äÇÏ´Ù¡±¶ó°í °Á¶Çß´Ù.